ChemoCentryx appoints Henry A. McKinnell, Jr. to board of directors
ChemoCentryx announced that Henry A. McKinnell, Jr, Ph.D., retired chairman and CEO of Pfizer, has been appointed to the Company's Board of Directors. Dr. McKinnell brings significant leadership in operations, international alliances, and commercial experience to ChemoCentryx. October 20, 2016